Skip to content

Clinical trials

Phase 2/3 Bipolar Disorder trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Bipolar Disorder Phase: Phase 2/3 Country / region: United States Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20061
20071
20102
20122
20151
20181
20221
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Terminated2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
NeuroRx, Inc.2
Biohaven Therapeutics Ltd.1
Charite University, Berlin, Germany1
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)1
Juvenile Bipolar Research Foundation1
Michigan State University1
The University of New South Wales1
Tufts Medical Center1
US Department of Veterans Affairs1
University of Pittsburgh1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Bipolar Disorder12
Depressive Disorder2
Psychotic Disorders2
Affective Disorders, Psychotic1
Major Depressive Disorder1
Mania1
Schizophrenia1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.